Literature DB >> 10751139

The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis.

J W IJdo1, J I Meek, M L Cartter, L A Magnarelli, C Wu, S W Tenuta, E Fikrig, R W Ryder.   

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging tickborne infection, increasingly recognized in areas in which Lyme disease is endemic, but there are few data on the incidence of HGE. Prospective population-based surveillance was conducted in the 12-town area around Lyme, Connecticut, by means of both active and passive methods, from April through November of 1997, 1998, and 1999. Five hundred thirty-seven residents presenting to their primary care provider with an acute febrile illness suggestive of HGE were identified. Of these, 137 (26%) had laboratory evidence (by indirect fluorescent antibody staining or polymerase chain reaction) of HGE; 89 were confirmed cases, and 48 were probable cases. The incidence of confirmed HGE was 31 cases/100,000 in 1997, 51 cases/100,000 in 1998, and 24 cases/100,000 in 1999. A subset of sera was tested by use of immunoblot assays, and results were in agreement with indirect fluorescent antibody methods for 86% of samples analyzed. Thus, HGE is an important cause of morbidity and is now the second most common tickborne infection in southeastern Connecticut.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751139     DOI: 10.1086/315389

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island.

Authors:  J W Ijdo; C Wu; L A Magnarelli; K C Stafford; J F Anderson; E Fikrig
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia.

Authors:  S Lotric-Furlan; T Avsic-Zupanc; M Petrovec; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.

Authors:  M Akkoyunlu; S E Malawista; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay.

Authors:  J W IJdo; C Wu; L A Magnarelli; E Fikrig
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Rapid, simple, and sensitive detection of Anaplasma phagocytophilum by loop-mediated isothermal amplification of the msp2 gene.

Authors:  Lei Pan; Lijuan Zhang; Guiqiang Wang; Qinghui Liu; Yanyan Yu; Shiwen Wang; Huilan Yu; Jing He
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 6.  The biological basis of severe outcomes in Anaplasma phagocytophilum infection.

Authors:  J Stephen Dumler
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-19

7.  Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome.

Authors:  Jacob W IJdo; Angel C Mueller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Outcomes of treated human granulocytic ehrlichiosis cases.

Authors:  Alan H Ramsey; Edward A Belongia; Craig M Gale; Jeffrey P Davis
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

9.  Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis.

Authors:  Jacob W IJdo; Caiyun Wu; Sam R Telford; Erol Fikrig
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 10.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.